NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma

Immunomodulators are effective in controlling hematologic malignancy by initiating or reactivating host antitumor immunity to otherwise poorly immunogenic and immune suppressive cancers. We aimed to boost antitumor immunity in B-cell lymphoma by developing a tumor cell vaccine incorporating α-galact...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood Jg. 120; H. 15; S. 3019
Hauptverfasser:	Mattarollo, Stephen R, West, Alison C, Steegh, Kim, Duret, Helene, Paget, Christophe, Martin, Ben, Matthews, Geoffrey M, Shortt, Jake, Chesi, Marta, Bergsagel, P Leif, Bots, Michael, Zuber, Johannes, Lowe, Scott W, Johnstone, Ricky W, Smyth, Mark J
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 11.10.2012
Schlagworte:	Adjuvants, Immunologic - administration & dosage Animals Cancer Vaccines - therapeutic use Cytotoxicity, Immunologic - immunology Female Flow Cytometry Galactosylceramides - administration & dosage Genes, myc - genetics Genes, T-Cell Receptor delta - physiology Humans Immunotherapy Interferon-gamma - metabolism Interleukin-12 - physiology Interleukin-18 - physiology Killer Cells, Natural - immunology Killer Cells, Natural - metabolism Killer Cells, Natural - pathology Lymphoma, B-Cell - immunology Lymphoma, B-Cell - metabolism Lymphoma, B-Cell - prevention & control Male Mice Mice, Inbred C57BL Mice, Knockout Mice, Transgenic Natural Killer T-Cells - immunology Natural Killer T-Cells - metabolism Natural Killer T-Cells - pathology Vaccination
ISSN:	1528-0020, 1528-0020
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!